As we recently announced, Absci is collaborating with Twist to design a novel antibody ... 101 program was shared at this event and can be found on Absci's website within our updated corporate deck ...

Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) today reported financial results for the third quarter ended September 30, 2024 and provided ...

Upcoming oral presentation for the ALLOHA TM Phase 1 heme trial at the 66 th American Society of Hematology (ASH) Annual Meeting and Exposition Company to host virtual KOL event featuring ... and ...

Completed a successful end of Phase 2 meeting with the FDA for bitopertin in erythropoietic protoporphyria (EPP), reaching alignment on all ...

Cash, cash equivalents and marketable securities of $372.8 million, including $172.7 million equity raise in September, expected to provide runway into 2028 ...

FCB NY took the Grand Prix for its work with Spotify and Area 23 received the President’s Award for its work with Siemens ...

Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today highlighted pipeline ...

Prothena expects to report multiple clinical readouts starting in mid-2025 and continuing throughout the year from the ongoing Phase 1 ASCENT clinical trials Prothena has currently enrolled ...

Earth ObserverEarth HomeEarth Observer HomeEditor's CornerFeature ArticlesMeeting SummariesNewsScience in the NewsCalendarsIn ...

Parabilis Medicines, Inc. ("Parabilis") focused on supporting the clinical development of Parabilis' lead program, FOG-001, in colorectal cancer. This collaboration ...

Subscribe to Sky Sports to watch live, or stream on NOW. You'll need a subscription that includes Sky Sports Main Event.